SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Glenmark Life Scienc - Quaterly Results

20 Apr 2022 Evaluate
The March 2022 quarter revenue stood at Rs. 5140.57 millions, up 10.04% as compared to Rs. 4671.63 millions during the corresponding quarter last year.The Net Profit of the company registered a slight decline of -5.53% to Rs. 988.97  millions from Rs. 1046.84 millions.The company reported a degrowth in operating Profit to 1473.06 millions from 1702.26 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202203 202103 % Var 202203 202103 % Var 202203 202103 % Var
Sales 5140.57 4671.63 10.04 21232.14 18851.65 12.63 21232.14 18851.65 12.63
Other Income 50.95 3.41 1394.13 147.04 8.11 1713.07 147.04 8.11 1713.07
PBIDT 1473.06 1702.26 -13.46 6307.64 5918.85 6.57 6307.64 5918.85 6.57
Interest 1.25 211.78 -99.41 279.62 875.47 -68.06 279.62 875.47 -68.06
PBDT 1471.81 1490.48 -1.25 6028.02 5043.38 19.52 6028.02 5043.38 19.52
Depreciation 95.54 84.26 13.39 378.77 333.94 13.42 378.77 333.94 13.42
PBT 1376.27 1406.22 -2.13 5649.25 4709.44 19.96 5649.25 4709.44 19.96
TAX 387.30 359.38 7.77 1462.01 1193.63 22.48 1462.01 1193.63 22.48
Deferred Tax 18.25 11.94 52.85 85.74 66.17 29.58 85.74 66.17 29.58
PAT 988.97 1046.84 -5.53 4187.24 3515.81 19.10 4187.24 3515.81 19.10
Equity 245.05 19.60 1150.26 245.05 19.60 1150.26 245.05 19.60 1150.26
PBIDTM(%) 28.66 36.44 -21.36 29.71 31.40 -5.38 29.71 31.40 -5.38

Alivus Life Sciences Share Price

1066.65 -6.50 (-0.61%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×